Home/Filings/4/0000059478-25-000218
4//SEC Filing

Van Naarden Jacob 4

Accession 0000059478-25-000218

CIK 0000059478other

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 4:15 PM ET

Size

6.3 KB

Accession

0000059478-25-000218

Insider Transaction Report

Form 4
Period: 2025-08-13
Van Naarden Jacob
EVP & Pres., Lilly Oncology
Transactions
  • Purchase

    Common Stock

    2025-08-13$647.36/sh+1,000$647,36020,561.985 total
Holdings
  • Common Stock

    (indirect: By Trust)
    4,342
  • Common Stock

    (indirect: By Spouse)
    4,302
Footnotes (1)
  • [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1
  • filerCIK 0001661254

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:15 PM ET
Size
6.3 KB